Combination Radiation Therapy and Imipridone ONC201 for the Treatment of Solid Tumors

被引：1
|
作者：
Jhawar, S. R. [1 ]
Goyal, S. [2 ]
Thandoni, A. [1 ]
Wu, H. [1 ]
Hassan, S. [3 ]
Schiff, D. S. [1 ]
Allen, J. [4 ]
Stogniew, M. [4 ]
Tarapore, R. [4 ]
Stein, M. [1 ]
Bertino, J. [1 ]
Haffty, B. G., Jr. [1 ]
Zloza, A. [1 ,5 ]
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
[3] Rutgers State Univ, New Brunswick, NJ USA
[4] Oncoceutics Inc, Philadelphia, PA USA
[5] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3424
引用
收藏
页码：E598 / E598
页数：1
相关论文
共 50 条
  • [41] Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma
    He, Ling
    Bhat, Kruttika
    Ioannidis, Angeliki
    Zhang, Le
    Nguyen, Nhan T.
    Allen, Joshua E.
    Nghiemphu, Phioanh Leia
    Cloughesy, Timothy F.
    Liau, Linda M.
    Kornblum, Harley I.
    Pajonk, Frank
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 140 - 147
  • [42] Imipridone ONC201 Blocks Tumor Growth by Inhibiting RET/IGFBP2 Pathway in Medullary Thyroid Cancer
    Bagheri-Yarmand, Rozita
    Tarapore, Rohinton
    Allen, Joshua
    Sherman, Steven
    Gagel, Robert
    PANCREAS, 2020, 49 (03) : 463 - 463
  • [43] Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies
    Prabhu, Varun V.
    Talekar, Mala K.
    Lulla, Amriti R.
    Kline, C. Leah B.
    Zhou, Lanlan
    Hall, Junior
    Van den Heuvel, A. Pieter J.
    Dicker, David T.
    Babar, Jawad
    Grupp, Stephan A.
    Garnett, Mathew J.
    McDermott, Ultan
    Benes, Cyril H.
    Pu, Jeffrey J.
    Claxton, David F.
    Khan, Nadia
    Oster, Wolfgang
    Allen, Joshua E.
    El-Deiry, Wafik S.
    CELL CYCLE, 2018, 17 (04) : 468 - 478
  • [44] Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model
    Kumar, Virender
    Sethi, Bharti
    Staller, Dalton W.
    Shrestha, Prakash
    Mahato, Ram I.
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [45] Potent synergistic tumor cell suppression from combination of ONC201 and epigenetic modulators EZH2 or HDAC inhibitors provides a novel treatment strategy for solid tumors
    Zhang, Yiqun
    Zhou, Lanlan
    Glantz, Michael
    Safran, Howard
    Seyhan, Attila
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2020, 80 (16)
  • [46] Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model
    Virender Kumar
    Bharti Sethi
    Dalton W. Staller
    Prakash Shrestha
    Ram I. Mahato
    Cell Death Discovery, 10
  • [47] Effect of combination of ONC201 and bevacizumab on colorectal cancer (CRC) growth and metastasis in vivo
    Ei-Deiry, Wafik S.
    Wagner, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
    Jackson, Evangeline R.
    Duchatel, Ryan J.
    Staudt, Dilana E.
    Persson, Mika L.
    Mannan, Abdul
    Yadavilli, Sridevi
    Parackal, Sarah
    Game, Shaye
    Chong, Wai Chin
    Jayasekara, W. Samantha N.
    Le Grand, Marion
    Kearney, Padraic S.
    Douglas, Alicia M.
    Findlay, Izac J.
    Germon, Zacary P.
    McEwen, Holly P.
    Beitaki, Tyrone S.
    Patabendige, Adjanie
    Skerrett-Byrne, David A.
    Nixon, Brett
    Smith, Nathan D.
    Day, Bryan
    Manoharan, Neevika
    Nagabushan, Sumanth
    Hansford, Jordan R.
    Govender, Dinisha
    McCowage, Geoff B.
    Firestein, Ron
    Howlett, Meegan
    Endersby, Raelene
    Gottardo, Nicholas G.
    Alvaro, Frank
    Waszak, Sebastian M.
    Larsen, Martin R.
    Colino-Sanguino, Yolanda
    Valdes-Mora, Fatima
    Rakotomalala, Andria
    Meignan, Samuel
    Pasquier, Eddy
    Andre, Nicolas
    Hulleman, Esther
    Eisenstat, David D.
    Vitanza, Nicholas A.
    Nazarian, Javad
    Koschmann, Carl
    Mueller, Sabine
    Cain, Jason E.
    Dun, Matthew D.
    CANCER RESEARCH, 2023, 83 (14) : 2421 - 2437
  • [49] Antitumor efficacy of combination treatment with ONC201 and enzalutamide or darolutamide in metastatic castration-resistant prostate cancer
    Wu, Jinxuan Laura
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Carneiro, Benedito
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] Combination of ONC201 and bevacizumab significantly impacts colorectal cancer growth and metastasis in vivo
    Wagner, Jessica
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2016, 76
12345